CY1111567T1 - Ενδιαμεσα διβενζο (b,f) αζεπινης - Google Patents
Ενδιαμεσα διβενζο (b,f) αζεπινηςInfo
- Publication number
- CY1111567T1 CY1111567T1 CY20111100572T CY111100572T CY1111567T1 CY 1111567 T1 CY1111567 T1 CY 1111567T1 CY 20111100572 T CY20111100572 T CY 20111100572T CY 111100572 T CY111100572 T CY 111100572T CY 1111567 T1 CY1111567 T1 CY 1111567T1
- Authority
- CY
- Cyprus
- Prior art keywords
- divenzo
- azepinis
- preparation
- processes
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
- C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
- C07D223/26—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a double bond between positions 10 and 11
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
- C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
- C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11
Abstract
Η εφεύρεση αναφέρεται σε καινούριες διαδικασίες για την παρασκευή του φαρμακευτικού σκευάσματος οξυκαρβαζεπίνη, καθώς επίσης και σε καινοτόμα ενδιάμεσα που παρασκευάζονται από ή που χρησιμοποιούνται στις αναφερόμενες διαδικασίες, και στην παρασκευή των εν λόγω ενδιάμεσων.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0002740.9A GB0002740D0 (en) | 2000-02-07 | 2000-02-07 | Organic compounds |
EP09153375A EP2067772B1 (en) | 2000-02-07 | 2001-02-07 | Dibenzo (b,f) azepine intermediates |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1111567T1 true CY1111567T1 (el) | 2015-10-07 |
Family
ID=9885081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111100572T CY1111567T1 (el) | 2000-02-07 | 2011-06-16 | Ενδιαμεσα διβενζο (b,f) αζεπινης |
Country Status (34)
Country | Link |
---|---|
US (1) | US7112673B2 (el) |
EP (2) | EP2067772B1 (el) |
JP (1) | JP4859322B2 (el) |
KR (5) | KR20080103608A (el) |
CN (2) | CN100455572C (el) |
AR (2) | AR029442A1 (el) |
AT (2) | ATE427938T1 (el) |
AU (1) | AU767724B2 (el) |
BR (1) | BR0107922A (el) |
CA (3) | CA2724295C (el) |
CO (1) | CO5271705A1 (el) |
CY (1) | CY1111567T1 (el) |
CZ (1) | CZ301572B6 (el) |
DE (2) | DE60138271D1 (el) |
DK (1) | DK2067772T3 (el) |
ES (2) | ES2324900T3 (el) |
GB (1) | GB0002740D0 (el) |
HK (1) | HK1052501A1 (el) |
HU (1) | HU229420B1 (el) |
IL (3) | IL150613A0 (el) |
MX (1) | MXPA02007629A (el) |
MY (1) | MY136474A (el) |
NO (1) | NO324949B1 (el) |
NZ (1) | NZ520329A (el) |
PE (1) | PE20011078A1 (el) |
PL (2) | PL217225B1 (el) |
PT (2) | PT1265868E (el) |
RU (1) | RU2303591C2 (el) |
SI (1) | SI2067772T1 (el) |
SK (1) | SK287217B6 (el) |
TR (1) | TR200201655T2 (el) |
TW (1) | TWI284638B (el) |
WO (1) | WO2001056992A2 (el) |
ZA (1) | ZA200206219B (el) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6670472B2 (en) | 2001-10-09 | 2003-12-30 | Max India Limited | Process for the preparation of 10-methoxycarbamazepine |
EP1302464A1 (en) * | 2001-10-09 | 2003-04-16 | Max India Limited | Process for preparation of 10-methoxycarbamazepine |
CA2486560A1 (en) * | 2002-06-14 | 2003-12-24 | Taro Pharmaceuticals U.S.A., Inc. | Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide |
ITMI20040452A1 (it) | 2004-03-09 | 2004-06-09 | Clariant Lsm Italia Spa | Processo per la preparazione di oxcarbazepina |
CN103012254A (zh) | 2005-05-10 | 2013-04-03 | 英特芒尼公司 | 用于调节应激-活化蛋白激酶***的吡啶酮衍生物 |
DE602007012236D1 (de) * | 2006-04-26 | 2011-03-10 | Supernus Pharmaceuticals Inc | Oxcarbazepin-zubereitungen für kontrollierte freisetzung mit sigmoidalem freisetzungsprofil |
US20090082335A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched oxcarbazepine |
CA3034994A1 (en) | 2008-06-03 | 2009-12-10 | Intermune, Inc. | Substituted aryl-2 pyridone compounds and use thereof for treating inflammatory and fibrotic disorders |
IN2015DN02296A (el) | 2012-09-26 | 2015-08-21 | Ranbaxy Lab Ltd | |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
WO2015038743A1 (en) * | 2013-09-11 | 2015-03-19 | The Administrators Of The Tulane Educational Fund | Novel anthranilic amides and the use thereof |
MX2016012808A (es) | 2014-04-02 | 2017-01-05 | Intermune Inc | Piridinonas anti-fibroticas. |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4847374A (en) * | 1987-01-27 | 1989-07-11 | Ciba-Geigy Corporation | Process for the manufacture of N,N-(Dibenzohexatrienylene)ureas |
IT1272897B (it) * | 1995-01-13 | 1997-07-01 | I F C Iniziative Finanziaarie | Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide |
US6355680B1 (en) * | 1996-02-20 | 2002-03-12 | Exocell, Inc. | Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
IT1283594B1 (it) * | 1996-04-12 | 1998-04-22 | Trifarma Srl | Derivati della 5h-dibenz- (b,f)-azepin-5-carbossiammide, loro preparazione e uso come sostanze ad azione medicinale |
WO1999001421A1 (en) * | 1997-07-01 | 1999-01-14 | Warner-Lambert Company | 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
US6048856A (en) * | 1997-12-17 | 2000-04-11 | Novo Nordisk A/S | Heterocyclic compounds |
-
2000
- 2000-02-07 GB GBGB0002740.9A patent/GB0002740D0/en not_active Ceased
-
2001
- 2001-02-05 PE PE2001000121A patent/PE20011078A1/es not_active Application Discontinuation
- 2001-02-05 AR ARP010100515A patent/AR029442A1/es not_active Application Discontinuation
- 2001-02-06 MY MYPI20010513A patent/MY136474A/en unknown
- 2001-02-06 CO CO01008602A patent/CO5271705A1/es active IP Right Grant
- 2001-02-07 RU RU2002123334/04A patent/RU2303591C2/ru not_active IP Right Cessation
- 2001-02-07 KR KR1020087027467A patent/KR20080103608A/ko not_active Application Discontinuation
- 2001-02-07 PL PL392476A patent/PL217225B1/pl unknown
- 2001-02-07 BR BR0107922-0A patent/BR0107922A/pt not_active Application Discontinuation
- 2001-02-07 PL PL356404A patent/PL214039B1/pl unknown
- 2001-02-07 AT AT01915203T patent/ATE427938T1/de active
- 2001-02-07 DK DK09153375.2T patent/DK2067772T3/da active
- 2001-02-07 US US10/182,980 patent/US7112673B2/en not_active Expired - Lifetime
- 2001-02-07 CA CA2724295A patent/CA2724295C/en not_active Expired - Fee Related
- 2001-02-07 SK SK1126-2002A patent/SK287217B6/sk not_active IP Right Cessation
- 2001-02-07 WO PCT/EP2001/001330 patent/WO2001056992A2/en active Application Filing
- 2001-02-07 HU HU0300243A patent/HU229420B1/hu unknown
- 2001-02-07 PT PT01915203T patent/PT1265868E/pt unknown
- 2001-02-07 SI SI200130996T patent/SI2067772T1/sl unknown
- 2001-02-07 ES ES01915203T patent/ES2324900T3/es not_active Expired - Lifetime
- 2001-02-07 ES ES09153375T patent/ES2363490T3/es not_active Expired - Lifetime
- 2001-02-07 CA CA002395601A patent/CA2395601C/en not_active Expired - Fee Related
- 2001-02-07 CA CA2639210A patent/CA2639210C/en not_active Expired - Fee Related
- 2001-02-07 TR TR2002/01655T patent/TR200201655T2/xx unknown
- 2001-02-07 JP JP2001556842A patent/JP4859322B2/ja not_active Expired - Lifetime
- 2001-02-07 KR KR1020077029687A patent/KR100931753B1/ko not_active IP Right Cessation
- 2001-02-07 AT AT09153375T patent/ATE505459T1/de active
- 2001-02-07 NZ NZ520329A patent/NZ520329A/en not_active IP Right Cessation
- 2001-02-07 CN CNB2005100853024A patent/CN100455572C/zh not_active Expired - Lifetime
- 2001-02-07 MX MXPA02007629A patent/MXPA02007629A/es active IP Right Grant
- 2001-02-07 EP EP09153375A patent/EP2067772B1/en not_active Expired - Lifetime
- 2001-02-07 EP EP01915203A patent/EP1265868B1/en not_active Expired - Lifetime
- 2001-02-07 KR KR1020097019039A patent/KR100966209B1/ko active IP Right Grant
- 2001-02-07 CN CNB018035302A patent/CN1244563C/zh not_active Expired - Lifetime
- 2001-02-07 IL IL15061301A patent/IL150613A0/xx unknown
- 2001-02-07 AU AU42373/01A patent/AU767724B2/en not_active Ceased
- 2001-02-07 DE DE60138271T patent/DE60138271D1/de not_active Expired - Lifetime
- 2001-02-07 CZ CZ20022676A patent/CZ301572B6/cs not_active IP Right Cessation
- 2001-02-07 DE DE60144456T patent/DE60144456D1/de not_active Expired - Lifetime
- 2001-02-07 PT PT09153375T patent/PT2067772E/pt unknown
- 2001-02-07 KR KR1020027010123A patent/KR20020071033A/ko not_active Application Discontinuation
- 2001-02-07 KR KR1020107000738A patent/KR101216285B1/ko not_active IP Right Cessation
- 2001-02-09 TW TW090102908A patent/TWI284638B/zh not_active IP Right Cessation
-
2002
- 2002-07-04 IL IL150613A patent/IL150613A/en not_active IP Right Cessation
- 2002-07-26 NO NO20023575A patent/NO324949B1/no not_active IP Right Cessation
- 2002-08-05 ZA ZA200206219A patent/ZA200206219B/en unknown
-
2003
- 2003-05-13 HK HK03103369.4A patent/HK1052501A1/xx not_active IP Right Cessation
-
2007
- 2007-12-17 IL IL188183A patent/IL188183A/en not_active IP Right Cessation
-
2010
- 2010-12-01 AR ARP100104442A patent/AR079237A2/es unknown
-
2011
- 2011-06-16 CY CY20111100572T patent/CY1111567T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111567T1 (el) | Ενδιαμεσα διβενζο (b,f) αζεπινης | |
CY1106032T1 (el) | Υποκατασταθεισες πυραζολες | |
CY1108101T1 (el) | Ενωσεις πυριμιδινης και η χρηση τους στην παρασκευη ενος τριαζολο-πυριμιδιν καρβα νουκλεοζιτη | |
CY1108067T1 (el) | Υποκατεστημενα παραγωγα 2-πυριδινο-κυκλοεξανο-1,4-διαμινης | |
CY1105227T1 (el) | Ενωσεις πιπepιδινης ως αντιαλλepγικα | |
CY1107294T1 (el) | Τοπικη συνθεση η οποια περιεχει τουλαχιστον μια βιταμινη d ή ενα αναλογο της βιταμινης d και τουλαχιστον ενα κορτικοστεροειδες | |
BG66084B1 (bg) | Циклопентаноиндоли, състави,съдържащи такива съединения и използването им | |
CY1109886T1 (el) | Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες | |
CY1105137T1 (el) | Παραγωγα αμινοκυκλοεξυλ αιθερων και χρησεις τους | |
SE0301653D0 (sv) | Novel compounds | |
CY1112267T1 (el) | Νεα πεπτιδια ως αναστολεις πρωτεασης ns3-σερινης του ιου ηπατιτιδας c | |
EA200401526A1 (ru) | Новые соединения и их применение | |
CY1106076T1 (el) | Παραγωγα γλυκοπυρανοσυλοξυβενζυλο βενζολιου και ιατρικες συνθεσεις που πepιεχουν τα ιδια | |
CY1110530T1 (el) | Ανοσοσφαιρινες που εξουδετερωνουν το nogoa για τη θεραπεια νευρολογικων ασθενειων | |
CY1110965T1 (el) | Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου | |
TR200200768T2 (tr) | Yeni kuinüklidin türevleri ve bunu içeren ilaç bileşimleri | |
CY1105247T1 (el) | Υποκατεστημενα παραγωγα c- κυκλοεξυλομεθυλαμινης | |
CY1111524T1 (el) | Νεα συντηγμενα πυρρολοκαρβαζολια | |
CY1109465T1 (el) | Νεες φαρμακευτικες φαρμακοτεχνικες μορφες μονταφινιλης | |
EA200301142A1 (ru) | Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6 | |
DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
ATE330017T1 (de) | Kallikrein gen | |
ATE398630T1 (de) | Zyklische conotoxin-peptide | |
SE9901077D0 (sv) | Novel use |